Immunotherapy in Small Cell Lung Cancer
Small-cell lung cancer (SCLC) is extremely sensitive to standard treatments, including conventional cytotoxic chemotherapies and radiotherapy, and has poor prognosis and short survival. Standard therapies have reached a plateau of effectiveness and new therapeutic strategies are needed to improve SC...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2019-06-01
|
| Series: | European Medical Journal |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/respiratory/article/immunotherapy-in-small-cell-lung-cancer/ |